Novel Therapies of Hepatitis B and D

Novel Therapies of Hepatitis B and D

Hepatitis B virus (HBV) infection is a global public health issue and is a major cause of cirrhosis and hepatocellular carcinoma (HCC). Hepatitis D virus (HDV) requires the hepatitis B surface antigen (HBsAg) to replicate. The eradication of HBV, therefore, can also cure HDV. The current therapies f...

Full description

Bibliographic Details
Main Authors:	Iman Waheed Khan, Mati Ullah Dad Ullah, Mina Choudhry, Mukarram Jamat Ali, Muhammad Ashar Ali, Sam L. K. Lam, Pir Ahmad Shah, Satinder Pal Kaur, Daryl T. Y. Lau
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Microorganisms
Subjects:	Hepatitis B virus (HBV) Hepatitis D virus (HDV) novel therapies siRNAs cccDNA inhibitors capsid assembly modulators
Online Access:	https://www.mdpi.com/2076-2607/9/12/2607

Similar Items

Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA
by: An-Qi Zhuang, et al.
Published: (2023-11-01)

Recent Advances in Hepatitis B Treatment
by: Georgia-Myrto Prifti, et al.
Published: (2021-05-01)

Hepatitis B Virus Capsid: The Core in Productive Entry and Covalently Closed Circular DNA Formation
by: Megan A. Mendenhall, et al.
Published: (2023-02-01)

Recent Advances in the Development of Sulfamoyl-Based Hepatitis B Virus Nucleocapsid Assembly Modulators
by: Sandesha Nayak, et al.
Published: (2023-11-01)

New Approaches to the Treatment of Chronic Hepatitis B
by: Alexandra Alexopoulou, et al.
Published: (2020-10-01)

Detection of HBV Covalently Closed Circular DNA
by: Xiaoling Li, et al.
Published: (2017-06-01)

Gene Editing Technologies to Target HBV cccDNA
by: Maria Guadalupe Martinez, et al.
Published: (2022-11-01)

Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment
by: Xiaomei Wang, et al.
Published: (2021-01-01)

Inflammatory Gene Expression Associates with Hepatitis B Virus cccDNA- but Not Integrant-Derived Transcripts in HBeAg Negative Disease
by: Andrea Magri, et al.
Published: (2022-05-01)

Efficacy of a combination of HBV RNA and HBeAg in predicting HBeAg seroconversion in patients treated with entecavir for 144 weeks
by: Xiaomei Wang, et al.
Published: (2020-10-01)

Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?
by: Sonia Alonso, et al.
Published: (2017-12-01)

A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation—and Beyond?
by: Sabrina Schreiner, et al.
Published: (2017-05-01)

Mechanism of Hepatitis B Virus cccDNA Formation
by: Lei Wei, et al.
Published: (2021-07-01)

Potential antiviral activities of chrysin against hepatitis B virus
by: Sajad Ahmad Bhat, et al.
Published: (2023-03-01)

The epigenetic control of hepatitis B virus modulates the outcome of infection
by: Lemonica eKoumbi, et al.
Published: (2016-01-01)

Evidence for long-term association of virion-delivered HBV core protein with cccDNA independently of viral protein production
by: Julie Lucifora, et al.
Published: (2021-10-01)

Animal Models for the Study of Hepatitis B Virus Pathobiology and Immunity: Past, Present, and Future
by: Xiaonan Zhang, et al.
Published: (2021-07-01)

Advances with RNAi-Based Therapy for Hepatitis B Virus Infection
by: Fiona van den Berg, et al.
Published: (2020-08-01)

Editorial: Interferon and its antiviral effect in response to HBV infection
by: Hongxiao Song, et al.
Published: (2023-02-01)

Liver-Humanized NSG-PiZ Mice Support the Study of Chronic Hepatitis B Virus Infection and Antiviral Therapies
by: Rossana Colón-Thillet, et al.
Published: (2023-06-01)

Crosstalk between Hepatitis B Virus and the 3D Genome Structure
by: João Diogo Dias, et al.
Published: (2022-02-01)

Evaluation of the HBV liver reservoir with fine needle aspirates
by: Barbara Testoni, et al.
Published: (2023-10-01)

HDV Pathogenesis: Unravelling Ariadne’s Thread
by: Eirini D. Tseligka, et al.
Published: (2021-04-01)

Chronic Hepatitis B Treatment Strategies Using Polymerase Inhibitor-Based Combination Therapy
by: Eriko Ohsaki, et al.
Published: (2021-08-01)

SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters
by: Dai-Qing Wu, et al.
Published: (2022-05-01)

A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genome
by: Robert L. Kruse, et al.
Published: (2021-04-01)

Cell Culture Systems for Studying Hepatitis B and Hepatitis D Virus Infections
by: Grace Sanghee Lee, et al.
Published: (2023-07-01)

Interferon and Hepatitis B: Current and Future Perspectives
by: Jianyu Ye, et al.
Published: (2021-09-01)

A Novel Mouse Model Harboring Hepatitis B Virus Covalently Closed Circular DNASummary
by: Zaichao Xu, et al.
Published: (2022-01-01)

When Hepatitis B Virus Meets Interferons
by: Guangyun Tan, et al.
Published: (2018-07-01)

Potential capacity of interferon-α to eliminate covalently closed circular DNA (cccDNA) in hepatocytes infected with hepatitis B virus
by: Gang Wang, et al.
Published: (2021-04-01)

Characterization of hepatitis B and delta coinfection in Israel
by: Rachel Shirazi, et al.
Published: (2018-02-01)

Review of Related Factors for Persistent Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma
by: Nevin Varghese, et al.
Published: (2024-02-01)

Illuminating the Live-Cell Dynamics of Hepatitis B Virus Covalently Closed Circular DNA Using the CRISPR-Tag System
by: Jiahui Ding, et al.
Published: (2023-04-01)

In vivo Delivery Tools for Clustered Regularly Interspaced Short Palindromic Repeat/Associated Protein 9-Mediated Inhibition of Hepatitis B Virus Infection: An Update
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2022-07-01)

The histone variant H3.3 regulates the transcription of the hepatitis B virus
by: Francisca Alvarez-Astudillo, et al.
Published: (2021-03-01)

Immunoinformatics and Evaluation of Peptide Vaccines Derived from Global Hepatitis B Viral HBx and HBc Proteins Critical for Covalently Closed Circular DNA Integrity
by: Umar Saeed, et al.
Published: (2023-11-01)

Improved Specificity and Safety of Anti-Hepatitis B Virus TALENs Using Obligate Heterodimeric <i>Fok</i>I Nuclease Domains
by: Tiffany Smith, et al.
Published: (2021-07-01)

CRISPR/Cas9 for hepatitis B virus infection treatment
by: Bo Cai, et al.
Published: (2023-05-01)

Prediction for HBsAg seroconversion in children with chronic hepatitis B
by: Yan-Wei Zhong, et al.
Published: (2021-12-01)